The aim of this study is to assess clinical efficacy of ceftazidime–avibactam for the management of carbapenem‐resistant Gram‐negative infections in renal patients receiving recommended dosing adjustments compared to those treated… Click to show full abstract
The aim of this study is to assess clinical efficacy of ceftazidime–avibactam for the management of carbapenem‐resistant Gram‐negative infections in renal patients receiving recommended dosing adjustments compared to those treated with scheduled full‐dose.
               
Click one of the above tabs to view related content.